If you or anyone you know has asthma, you may have heard of the drug Xolair (Omalizumab). Xolair is what is known as a monoclonal antibody drug. To explain how the drug works, understanding what a monoclonal antibody is is important. A monoclonal antibody is an antibody produced in vitro that only recognizes a single epitope on an antigen. Conversely, polyclonal antibodies recognize multiple epitopes of an antigen. Both are useful in various immunoassays; however, monoclonal antibodies also have great therapeutic use due to their specificity.
Xolair is an injectable monoclonal antibody drug used against severe asthma that cannot be well managed by common medications such as inhaled corticosteroids. Most asthma results from an allergic reaction in the lower respiratory tract. Allergic reactions occur when a person has an antibody response to a harmless substance. When a person encounters an allergen, their body begins to produce IgE antibodies against that substance. The next time a person is exposed, the IgE antibodies on mast cells and basophils bind to the allergen and stimulate the release of proinflammatory mediators causing the allergic reaction. In this case, that inflammation occurs in the airways, causing what we know as asthma. Xolair is a monoclonal antibody that binds to free IgE, preventing it from attaching itself to mast cells and basophils, thus preventing immune response that causes an allergic reaction.
This drug can be very beneficial to people who suffer from asthma. However, there are many possible side effects.
Possible side effects include:
- Anaphylaxis
- Cancer
- Heart and circulation problems
- Parasitic infections
- Pain in arms and legs
- Dizziness
- Skin rash
- Bone fractures
- Pain or discomfort in ears
- Tiredness
- Headache
- Fever
- Sore throat
- Nausea and/or vomiting
- Nose bleeds
One of the biggest risks is severe allergic reaction leading to anaphylaxis. Due to this people who are given Xolair are monitored by their healthcare provider during and after they receive the injection. Another important side effect is that risk of parasitic infection is significantly increased while taking Xolair as IgE, which is used to fight off parasitic infections, is inactivated. Most of the side effects that occur when taken Xolair are thought to be a result of reduction of oral corticosteroids. It is thought increased risk of cancer may be due to the drug’s immunosuppressive activity.

